Home
About Us
FAQ
Contact Us
Media Tools
ExpertConnect App
MyExpertNet
University Partners
Becoming a Partner
Key Organizations
Search Assistance
Help
Project Profile
Share
QR code
EVALUATION OF NOVEL COMPOUNDS POTENTIALLY TARGETING CENTRAL SIGMA RECEPTORS REGARDING THEIR ABILITY TO LOWER BLOOD GLUCOSE IN DIABETIC MICE.
Sponsoring Agency:
ALCHEM LABORATORIES, INC
Investigators
Mark Atkinson
Professor
Md-Pathology, College-Medicine
atkinson@ufl.edu
Charles Frazier
Professor and Chair
Ph-Cell and Sys Pharm, College-Pharmacy
cjfraz@ufl.edu
Jay McLaughlin
Professor and The Cvs/Pharmacy Inc Professorship
Ph-Cell and Sys Pharm, College-Pharmacy
jmclaughlin@cop.ufl.edu
Funding
Award
$6,863.00
Begin Date
February 1, 2024
End Date
July 31, 2025
Research Terms
Pharmacology
Industries
Pharmaceuticals
Keyword Search
Please enter valid search criteria.
Search
Centers
Experts
Projects
Publications
Speakers
Stories
Technologies
Videos
University
All Universities
Florida A&M University
Florida Atlantic University
Florida Gulf Coast University
Florida Institute of Technology
Florida International University
Florida State University
University of Central Florida
University of Florida
University of Miami
University of North Florida
University of South Florida
University of West Florida
Browse by STEM
Biotechnology
Computer Science
Energy
Engineering
Environmental Sciences
Information Science
Life Sciences
Mathematics
Medical Sciences
Military Sciences
Natural Sciences
Physical Sciences
Plant Sciences
Science
Space Sciences
Technology
Transportation